DayTwo provides personalized Medical Nutrition Therapy to enable the normalization of blood sugar levels based on an individual’s unique gut-microbiome profile.

Our science rests on 10 years of evidence-based research completed at the Weizmann Institute of Science, published in Cell and later validated by the Mayo Clinic in JAMA. It concluded blood sugar levels in response to foods are highly individualized and therefore can positively impact people with Type II Diabetes.

The nutrition solution, which includes carbs as 30-35% of the personalized recommendations, reduces impact on lifestyle and eliminates negative and significant health risks associated with fad diets, including the ketogenic diet, while increasing adherence and positively impacting blood sugar.

Merck is an innovative, global healthcare leader that is committed to improving health and wellbeing around the world. Our core product categories include diabetes, cancer, vaccines and hospital acute care. We continue to focus our research on conditions that represent some of today’s most significant health challenges – like cancer, HIV, HPV, hepatitis C, cardio-metabolic disease, antibiotic-resistant infection and Alzheimer’s disease, and we are on the front lines in the fight against emerging global pandemics, such as Ebola. We also devote extensive time and energy to increasing access to medicines and vaccines through far-reaching programs that donate and deliver our products to the people who need them. At Merck, we’re applying our global reach, financial strength and scientific excellence to do more of what we’re passionate about: improving health and improving lives.

Abbvie

We’re a company that takes on the toughest health challenges. But we do more than treat diseases—we aim to make a remarkable impact on people’s lives. We are AbbVie, a highly focused research-driven biopharmaceutical company.

Our more than 29,000 employees are scientists, researchers, communicators, manufacturing specialists and regulatory experts located around the globe. We come up with new approaches to addressing today’s health issues—from life-threatening illness to chronic conditions.

Greenwich Biosciences

Greenwich Biosciences is at the forefront of cannabinoid science, leveraging nearly two decades of pioneering investment and research by our parent company GW Pharmaceuticals plc. Our legacy is rooted in unlocking the potential of cannabinoid prescription medicines to address serious conditions that currently have limited or no treatment options.Greenwich Biosciences is the first and only company to pursue and receive FDA approval for a plant-derived cannabinoid therapy that addresses difficult to treat conditions with significant unmet needs.

National Hemophilia Foundation

The National Hemophilia Foundation (NHF) is dedicated to finding better treatments and cures for inheritable bleeding disorders and to preventing the complications of these disorders through education, advocacy and research. Established in 1948, the National Hemophilia Foundation has chapters throughout the country. Its programs and initiatives are made possible through the generosity of individuals, corporations and foundations as well as through a cooperative agreement with the Centers for Disease Control and Prevention (CDC).

PCORI

PCORI is authorized by Congress to conduct research to provide information about the best-available evidence to help patients and their health care providers make better-informed health and healthcare decisions. PCORI’s research, which is guided by input from stakeholders across the healthcare community, is intended to give patients and those who care for them with a better understanding of the prevention, treatment and care options available, and the science that supports those options. PCORI is committed to improving health by substantially increasing the quantity, quality, and timeliness of useful, trustworthy information available to support health decisions; speeding the implementation of patient-centered knowledge into practice; and influencing clinical and health care research funded by others to be more patient-centered. For PCORI more information about PCORI, sign up for our email newsletters via www.pcori.org/signup or follow us on Twitter at @PCORI: http://bit.ly/1gix7t5.

Kaiser Permanente

Kaiser Permanente is one of America’s leading integrated health care providers and not-for-profit health plans. With annual operating revenue of more than $82 billion, Kaiser Permanente serves more than 12 million members in eight states and the District of Columbia.

Takeda

i. Takeda Pharmaceutical Company Limited is a global, research and development-driven pharmaceutical company committed to bringing better health and a brighter future to patients by translating science into life-changing medicines. Takeda focuses its R&D efforts on oncology, gastroenterology and neuroscience therapeutic areas plus vaccines. Takeda conducts R&D both internally and with partners to stay at the leading edge of innovation. Around 30,000 Takeda employees are committed to improving quality of life for patients, working with Takeda’s partners in health care in more than 70 countries.

Lundbeck, a global pharmaceutical company based in Denmark and founded in 1915, strives for global leadership in psychiatry and neurology by improving the lives of patients. One of the world’s leading companies specializing in brain disorders, Lundbeck is focused on innovating treatments for depression, schizophrenia, Parkinson’s disease and Alzheimer’s disease.

Total Brain

THE PERFORMANCE OF YOUR COMPANY DEPENDS ON THE BRAIN PERFORMANCE OF YOUR EMPLOYEES.

With 44M Americans suffering from a mental health condition and over 50% of mental conditions going undiagnosed, it’s no surprise that mental health issues that affect employee productivity and performance are at an all-time high.

Total Brain is an innovative mental health & fitness platform that looks at the entire set of interconnected brain capacities that drive an individual’s performance. Through careful assessment, screening and benchmarking, we provide scientifically-based mental fitness programs that help improve deficiencies in individual brain capacities that can hinder employee productivity and negatively impact your bottom line.

i. AscellaHealth is a Specialty Pharmacy Benefit Management ("SPBM") company located in the greater Philadelphia, Pennsylvania area having been in operation since 2009. Founded by a team of industry leaders, we are a national SPBM serving all types of healthcare segments including commercial and government lines of business. AscellaHealth offers high quality medical and prescription drug management services along with other customizable services, such as carved-out specialty pharmacy services and cost-savings programs. AscellaHealth provides access to a high‐touch service model offering competitive pricing, improved access to limited distribution (specialty) drugs, clinical programs for complex conditions, medical drug management and copay assistance programs. Using proprietary financial models, combined with superior technology and analytics, we offer flexible, tailored drug management solutions driven by actual client needs. AscellaHealth has extensive experience in directing J code drug management to the pharmacy benefit and vice versa to provide optimal savings and quality of care for patients and the payer. This includes managing different sites of care including physician offices, hospital settings to alternative sites of care, including home and free-standing outpatient settings to enhance and support high-touch patient care at cost-savings for the payer. With AscellaHealth, you get sophisticated SPBM services which promote proven, exceptional cost-savings, while supporting appropriate access and quality care. http://www.ascellahealth.com

Beaumont Employer Services is a division of Beaumont Health, Michigan’s largest health care system (based on inpatient admissions and net patient revenue). Beaumont Employer Services is powered by the Beaumont Network of healthcare providers and facilities and works directly with companies of every size to change how their employees access and pay for health care services. The goal of employer services is to partner with employers to create innovative solutions to reduce health care cost and improve quality and patient experience. Services provided range from occupational health services, condition-based episodes of care programs, ER diversion strategies, care coordination and member concierge programs, narrow network solutions, and risk based models. Products and programs are flexible and customizable by employer. Visit https://www.beaumontemployerservices.org/ to learn more.

Ginger is reinventing mental healthcare by coupling data science and virtual delivery to provide immediate, personal support for anyone. Care from our on-demand mental health system is delivered through the Ginger app, available on iOS and Android, where members can conveniently connect with Ginger’s team of behavioral health coaches - 24/7, 365 days a year. For those in need of additional support, a therapist or psychiatrist can be added to their care team. Over 700,000 people have access to Ginger through leading employers, health plans, and other partners. The World Economic Forum has identified Ginger’s AI technology as a Technology Pioneer, and the company was recognized as one of the top 10 Most Innovative Companies in Healthcare by Fast Company.

We are Janssen, the Pharmaceutical Companies of Johnson & Johnson. We are focused on treating and preventing some of the most complex and devastating diseases of our time in oncology, immunology, neuroscience, infectious diseases & vaccines, cardiovascular & metabolism, and pulmonary hypertension. We pursue the most promising science, wherever it might be found. Learn more at www.janssen.com

The National Pharmaceutical Council (NPC) is a health policy research organization focused on the role and value of innovative medicines to improve patients’ health. We conduct research, host educational events, and collaborate with partners on the issues of evidence, value, access, and innovation. In recent years, NPC’s peer-reviewed research has focused on helping payers, policymakers, patients, and providers understand the challenges of solely looking at the cost of therapies and the importance of fully realizing the lifetime value biopharmaceuticals bring to our entire health care system. Founded in 1953 and supported by the nation’s major research-based biopharmaceutical companies, NPC’s established credibility and expertise on critical industry issues offers an inclusive opportunity for collaboration, research, and education with multiple stakeholders. Furthermore, our work complements other life science organizations by providing the research and resources that underlie many of the ongoing health policy debates.

Omada Health is a leading digital care company that offers innovative and clinically effective digital health programs to empower individuals to engage in their health and lead healthier lives. The program is personalized to meet each participant’s unique needs as they evolve, ranging from diabetes prevention, type 2 diabetes management, hypertension, behavioral health, and musculoskeletal issues. Omada combines professional health coaching, connected health devices, real-time data and personalized feedback to deliver clinically meaningful results. The company is the largest CDC-recognized provider of the National Diabetes Prevention Program. To learn more, visit www.omadahealth.com.

Progyny provides a best - in - class fertility benefits solution for self-insured employers. Our innovative fertility and family building benefits deliver superior outcomes, a shorter time to pregnancy, and reduced maternity and NICU costs - bringing greater value to employers and transforming employees' lives. Through our differentiated approach to benefits plan design, patient education and support, and active network management, our clients' employees are able to pursue the most effective treatment from the best fertility specialists and achieve optimal outcomes in cost-efficient manner, while our clients achieve savings in upfront treatment costs as well as reduced maternity and NICU expenses.

US-RX Care delivers Pharmacy Benefit Risk Management unlike any other service offered by pharmacy benefit managers (PBMs) of any kind, anywhere in the US. We provide fiduciary pharmacy risk management to self-insured employers with a singular focus on balancing cost and quality care in the best interest of plan sponsors and their plan participants. We are obsessed with service and quality of care - with no financial conflict of interest, no hidden profits and unrestricted transparency. Our services include programs for non-specialty medications, specialty medications and medical billed specialty medications. Our savings are guaranteed and we have saved our clients over $1 Billion.

i. Vera Whole Health is at the vanguard of a health revolution and a national leader in advanced primary care. Our model is uniquely designed to help people achieve optimum social, psychological, and physical well-being -- an outcome that’s neither probable nor affordable within the current sick-care system. We’re also the first provider in the United States to earn a Certificate of Validation by the Validation Institute for sound population health cost outcomes. https://www.verawholehealth.com/about

WellSpark delivers a full suite of well-being products and solutions for businesses, municipalities, and consumers. Participants benefit from robust education to improve health literacy, promote early detection of diseases and provide condition management through coaching, care coordination, social services and more. By identifying social determinants and behavioral barriers preventing proper self-care, WellSpark programs can empower individuals to embrace healthier lifestyles. We are a leading health and wellness company that administers one of the largest value-based wellness programs in the country. Our wellness platform is certified for information security by the Health Information Trust (HITRUST) Alliance, our health risk assessment earned the Wellness and Health Promotion certification from the National Committee for Quality Assurance (NCQA) and our pre-diabetes program is fully certified by the CDC.

Effective Member Engagement +
Innovative Business Model = Real Value and Results

Flipt empowers and incentivizes members to make better prescription purchasing decisions - decisions that are in their best interest and in the best interest of the plan, optimizing health outcomes. For the first time, members have accurate information, state-of-the-art tools, and strong financial incentives to make better decisions regarding the drugs they take and where they are filled.
Flipt operates a 100% passthrough business model aligned with the interests of the corporate plan sponsor and the plan members they are charged to represent.
What's the bottom-line? With Flipt, plan sponsors and members have the power of choice in their hands and can save 30-40% of their current pharmacy benefit spend.

GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on saving lives and improving health by pioneering new technologies for early cancer detection. The company is using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art computer science and data science to overcome one of medicine’s greatest challenges with Galleri™, GRAIL’s multi-cancer early detection test. An earlier version of Galleri demonstrated the ability to detect more than 50 types of cancers -- over 45 of which lack recommended screening tests today -- with a low false positive rate of less than 1%. When a cancer is detected, Galleri localizes the cancer signal with high accuracy, all from a single blood draw. GRAIL is headquartered in Menlo Park, California, with locations in Washington, D.C., North Carolina, and the United Kingdom. It is supported by leading global investors and pharmaceutical, technology, and healthcare companies.

Pacira BioSciences, Inc. (NASDAQ: PCRX) is a leading provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for health care practitioners and their patients. The company’s long-acting local analgesic, EXPAREL® (bupivacaine liposome injectable suspension) was commercially launched in the United States in April 2012. EXPAREL utilizes DepoFoam®, a unique and proprietary product delivery technology that encapsulates drugs without altering their molecular structure, and releases them over a desired period of time. In April 2019, the company acquired the iovera⁰ system, a handheld cryoanalgesia device used to deliver precise, controlled doses of cold temperature only to targeted nerves. To learn more about Pacira, including the corporate mission to reduce overreliance on opioids, visit www.pacira.com.

Our story started when our co-founders, whilst working as medical doctors, recognized that the holistic textbook version of medicine was not at all what was being provided for patients. The reality is that a stretched healthcare system fails to engage people in their medical care at the preventative stages. As a result, the $3 trillion currently spent on healthcare goes on to prevents only 10% of premature deaths. With digital therapeutics, we have the opportunity to prevent 40% of premature deaths that are caused by behavioural patterns. At Quit Genius, we are inventing a new class of healthcare technology designed to treat addictions and prevent disease. Quit Genius began as a direct-to-consumer tobacco cessation application. Recently, we have expanded our distribution strategy to target self-insured employers. Simultaneously, Quit Genius has grown its product offerings to include substance use disorder, most notably alcohol and opioids. Our objective is to make Quit Genius’ life saving technology available to help 100 million people quit their addictions.

Thrive Earlier Detection Corp. is a healthcare company focused on incorporating earlier cancer detection into routine medical care to extend and save lives. Thrive is developing CancerSEEK, a liquid biopsy test that is designed to detect many cancers at earlier stages of disease. CancerSEEK will serve as the core of Thrive’s integrated cancer information offering. For more information, please visit www.thrivedetect.com.

Vida’s award-winning, evidence-based virtual polychronic care platform brings together the power of human connection, psychology, and expertise to drive the long-term behaviors that lead not only to better management of chronic conditions, but prevention and even reversal as well. The program is a mobile-first experience uniquely personalized to each user through a combination of provider expertise and machine learning algorithms that use data from 100+ app and device integrations, as well as medical claims data, biometric data, and more to personalize the program and content.

Vida is polychronic by design and so naturally offers programs to treat a full spectrum of chronic conditions and the behavioral conditions that accompany them. Vida’s program offerings are grounded in the belief that every chronic condition is also a behavioral condition, and that good health follows good habits. Vida’s users accomplish lasting results through treating the body and the mind.